Isoform-selective Anti-TGF-beta antibodies and methods of use

MYPI2026002266A0Undetermined Publication Date: 2021-09-19GENENTECH INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2026002266
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-06-26
Filing Date
2021-03-18
Publication Date
2021-09-19
Patent Text Reader

Abstract

The invention provides isoform-selective anti-TGF β antibodies and methods of using the same. In particular, isoform-selective anti-TGF β2, anti-TGF β3, and anti-TGF β 2 / 3 monoclonal antibodies are provided, e.g., for the treatment of fibrosis and other TGF β-related disorders. (FIG. 3A)
Need to check novelty before this filing date? Find Prior Art